We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Approach Cooks Cancer Cells

By Biotechdaily staff writers
Posted on 17 Aug 2005
A new approach to killing tumors uses the beam from a near-infrared laser to heat carbon nanotubes that have been selectively directed to the cancer cells.

While biologic systems are highly transparent to 700-1,100 nm near-infrared (NIR) light, a solution of carbon nanotubes exposed to NIR light warms to about 70oC within two minutes. More...
Investigators at Stanford University (Palo Alto, CA, USA) have exploited this property of carbon nanotubes to selectively destroy cancer cells.

They coated nanotubes with folate molecules that directed the nanotubes to folate receptors on the cancer cell membranes. After the cells took up the nanotubes, the tumors were exposed to NIR laser light. The light caused the nanotubes to heat up, and the heat killed the cells. Nearby normal cells with no nanotubes were not damaged by the laser treatment. These findings were published in the August 8, 2005, online edition of the Proceedings of the [U.S.] Academy of Sciences.

"One of the longstanding problems in medicine is how to cure cancer without harming normal body tissue,” explained senior author Dr. Hongjie Dai, associate professor of chemistry at Stanford University. "We are using an intrinsic property of nanotubes to develop a weapon that kills cancer.”




Related Links:
Stanford University

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.